India's Biocon plans IPO for biosimilars business by March 2026

India's Biocon plans IPO for biosimilars business by March 2026

Photo by National Cancer Institute on Unsplash

31 January, 2025

Biocon Biosimilars

Printed by Unregistered user on Sat, 06 Dec 2025 05:20:35 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India: Eris Lifesciences to acquire Biocon Biologics's nephrology & dermatology unit

India's Serum Institute to double investment in Biocon Biologics to $300m

Read more from India

Meesho raises $28b in India IPO as institutional investors pile in

Zoho, Lingotto pump $45m into Indian electric bike company Ultraviolette